Основная статистика
| CIK | 1666700 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to DuPont de Nemours, Inc.
SEC Filings (Chronological Order)
На этой странице представлен полный хронологический список документов SEC, за исключением документов о собственности, которые мы предоставляем в других местах.
| September 3, 2025 |
DuPont Announces Commencement of Exchange Offers and Consent Solicitations for Senior Notes EX-99.1 Exhibit 99.1 NEWS RELEASE DuPont Announces Commencement of Exchange Offers and Consent Solicitations for Senior Notes WILMINGTON, DEL., September 2, 2025 – DuPont de Nemours, Inc. (NYSE: DD) (“DuPont”) announced today the commencement of offers to exchange any and all of its outstanding senior notes of the series listed in the table below (the “Existing Notes”) for new notes to be issued b |
|
| September 3, 2025 |
Intended Electronics Separation Exhibit 99.1 Intended Electronics Separation On January 15, 2025, DuPont announced it is targeting November 1, 2025, for the completion of the intended separation of its Electronics business, which includes its semiconductor technologies and interconnect solutions businesses (the “Intended Electronics Separation”) by way of a spin-off transaction, thereby creating a new independent public company |
|
| September 3, 2025 |
UNAUDITED PRO FORMA COMBINED FINANCIAL STATEMENTS Exhibit 99.2 UNAUDITED PRO FORMA COMBINED FINANCIAL STATEMENTS Overview On May 22, 2024 DuPont announced its plan to separate its Electronics business by way of a spin-off transaction, thereby creating a new independent, publicly traded electronics company to be known as Qnity Electronics, Inc (“Qnity”). Upon the satisfaction or waiver by DuPont of the conditions to the Intended Electronics Separa |
|
| September 3, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 2, 2025 DuPont de Nemours, Inc. (Exact name of registrant as specified in its charter) Delaware 001-38196 81-1224539 (State or other jurisdiction of incorporation) (Commissi |
|
| September 3, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 2, 2025 DuPont de Nemours, Inc. (Exact name of registrant as specified in its charter) Delaware 001-38196 81-1224539 (State or other jurisdiction of incorporation) (Commissi |
|
| September 2, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 2, 2025 (August 29, 2025) DuPont de Nemours, Inc. (Exact name of registrant as specified in its charter) Delaware 001-38196 81-1224539 (State or other jurisdiction of incorp |
|
| September 2, 2025 |
EX-2.1 Exhibit 2.1 EXECUTION VERSION TRANSACTION AGREEMENT BY AND AMONG DUPONT DE NEMOURS, INC., ARC FALCON HOLDINGS LP SOLELY FOR THE PURPOSES OF SECTION 1.1, SECTION 2.2(C), SECTION 2.3(H) SECTION 2.6, ARTICLE IV, SECTION 5.3, SECTION 5.24, SECTION 5.30, SECTION 6.3, SECTION 7.19(B), SECTION 7.21, ARTICLE VIII, SECTION 9.4(B), SECTION 10.5 AND ARTICLE XI (AND PROVISIONS INCIDENTAL THERETO) OF TH |
|
| August 29, 2025 |
EX-99.1 Exhibit 99.1 NEWS RELEASE DuPont Announces Agreement to Divest Aramids Business to Arclin • Transaction structure maximizes shareholder value, enables participation in future upside potential of combined new entity • Divestiture further streamlines the new DuPont portfolio and improves its financial profile WILMINGTON, Del., Aug. 29, 2025 – DuPont (NYSE: DD) today announced that Arclin, a |
|
| August 29, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 29, 2025 (August 29, 2025) DuPont de Nemours, Inc. (Exact name of registrant as specified in its charter) Delaware 001-38196 81-1224539 (State or other jurisdiction of incorpor |
|
| August 15, 2025 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 15, 2025 (August 15, 2025) DuPont de Nemours, Inc. (Exact name of registrant as specified in its charter) Delaware 001-38196 81-1224539 (State or other jurisdiction of incorporation) (Commis |
|
| August 12, 2025 |
EX-99.1 Exhibit 99.1 NEWS RELEASE DUPONT DE NEMOURS, INC. AND QNITY ELECTRONICS, INC. ANNOUNCE PRICING OF SENIOR SECURED NOTES AND SENIOR NOTES Notes to be the obligation solely of Qnity Electronics, Inc. as issuer following consummation of DuPont’s intended Spin-Off of its electronics business WILMINGTON, DEL., August 12, 2025 – DuPont de Nemours, Inc. (NYSE: DD) (“DuPont”) and Qnity Electronics, |
|
| August 12, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 12, 2025 (August 12, 2025) DuPont de Nemours, Inc. (Exact name of registrant as specified in its charter) Delaware 001-38196 81-1224539 (State or other jurisdiction of incorpor |
|
| August 11, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 11, 2025 (August 11, 2025) DuPont de Nemours, Inc. (Exact name of registrant as specified in its charter) Delaware 001-38196 81-1224539 (State or other jurisdiction of incorpor |
|
| August 11, 2025 |
EX-99.1 Exhibit 99.1 NEWS RELEASE DUPONT DE NEMOURS, INC. AND QNITY ELECTRONICS, INC. ANNOUNCE OFFERING OF SENIOR SECURED NOTES AND SENIOR NOTES Notes to be the obligation solely of Qnity Electronics, Inc. as issuer following consummation of DuPont’s intended Spin-Off of its electronics business WILMINGTON, DEL., August 11, 2025 – DuPont de Nemours, Inc. (NYSE: DD) (“DuPont”) and Qnity Electronics |
|
| August 5, 2025 |
DuPont Reports Second Quarter 2025 Results Exhibit 99.1 DuPont Reports Second Quarter 2025 Results •Net Sales of $3.3 billion increased 3%; organic sales increased 2% versus year-ago period •GAAP Income from continuing operations of $238 million; operating EBITDA of $859 million •GAAP EPS from continuing operations of $0.54; adjusted EPS of $1.12 •Cash provided by operating activities from continuing operations of $381 million; transaction |
|
| August 5, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-38196 DUPONT DE NEMOURS, INC. (Exact name of registrant as sp |
|
| August 5, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 5, 2025 DuPont de Nemours, Inc. (Exact name of registrant as specified in its charter) Delaware 001-38196 81-1224539 (State or other jurisdiction of incorporation) (Commission |
|
| August 4, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 4, 2025 (August 3, 2025) DuPont de Nemours, Inc. (Exact name of registrant as specified in its charter) Delaware 001-38196 81-1224539 (State or other jurisdiction of incorporat |
|
| August 4, 2025 |
njdepdupontjco MATTHEW J. PLATKIN ATTORNEY GENERAL OF NEW JERSEY R.J. Hughes Justice Complex 25 Market Street, P.O. Box 093 Trenton, New Jersey 08625-0093 Attorney for Plaintiffs By: Gwen Farley Deputy Attorney General Attorney ID No. 000081999 Ph. (609) 376-2740 [email protected] UNITED STATES DISTRICT COURT DISTRICT OF NEW JERSEY NEW JERSEY DEPARTMENT OF ENVIRONMENTAL PROTECTION; THE COM |
|
| July 23, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 23, 2025 (July 22, 2025) DuPont de Nemours, Inc. (Exact name of registrant as specified in its charter) Delaware 001-38196 81-1224539 (State or other jurisdiction of incorporatio |
|
| June 13, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 11-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 11-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 OR o TRANSITION REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-38196 A. |
|
| May 28, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 28, 2025 (May 22, 2025) DuPont de Nemours, Inc. (Exact name of registrant as specified in its charter) Delaware 001-38196 81-1224539 (State or other jurisdiction of incorporation) |
|
| May 15, 2025 |
Exhibit 1.01 DuPont de Nemours, Inc. Conflict Minerals Report BACKGROUND This Conflict Minerals Report (this “Report”) of DuPont de Nemours, Inc. (“DuPont” or the “Company”), provides information with respect to products for which Conflict Minerals are “necessary to the functionality or production” that were manufactured by or contract manufactured for the Company and its consolidated subsidiaries |
|
| May 15, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM SD Specialized Disclosure Report DuPont de Nemours, Inc. (Exact name of registrant as specified in its charter) Delaware 001-38196 81-1224539 (State or other jurisdiction of incorporation) (Commission file number) (IRS Employer Identification No.) 974 Centre Road, Building 730 Wilmington, DE 19805 (Address of principal ex |
|
| May 2, 2025 |
DuPont Reports First Quarter 2025 Results Exhibit 99.1 DuPont Reports First Quarter 2025 Results •Net Sales of $3.1 billion increased 5%; organic sales increased 6% versus year-ago period •GAAP Loss from continuing operations of $(548) million, includes $768 million non-cash goodwill impairment charge related to first quarter segment realignment; operating EBITDA of $788 million •GAAP EPS from continuing operations of $(1.33); adjusted EP |
|
| May 2, 2025 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 2, 2025 DuPont de Nemours, Inc. (Exact name of registrant as specified in its charter) Delaware 001-38196 81-1224539 (State or other jurisdiction of incorporation) (Commission fil |
|
| May 2, 2025 |
Exhibit 99.1 EXPLANATORY NOTE DuPont de Nemours, Inc., (the “Registrant”) is filing this Exhibit 99.1 to recast the consolidated financial statements of the Registrant together with its consolidated subsidiaries (collectively “DuPont” or the “Company”) in the Company's Annual Report on Form 10-K for the year ended December 31, 2024 filed with the U.S. Securities and Exchange Commission (“SEC”) on |
|
| May 2, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-38196 DUPONT DE NEMOURS, INC. (Exact name of registrant as s |
|
| May 2, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 2, 2025 DuPont de Nemours, Inc. (Exact name of registrant as specified in its charter) Delaware 001-38196 81-1224539 (State or other jurisdiction of incorporation) (Commission fil |
|
| April 4, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 4, 2025 DuPont de Nemours, Inc. (Exact name of registrant as specified in its charter) Delaware 001-38196 81-1224539 (State or other jurisdiction of incorporation) (Commission f |
|
| April 3, 2025 |
DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE (RULE 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission On |
|
| April 3, 2025 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE (RULE 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Com |
|
| March 17, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 17, 2025 DuPont de Nemours, Inc. (Exact name of registrant as specified in its charter) Delaware 001-38196 81-1224539 (State or other jurisdiction of incorporation) (Commission |
|
| February 21, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 21, 2025 DuPont de Nemours, Inc. (Exact name of registrant as specified in its charter) Delaware 001-38196 81-1224539 (State or other jurisdiction of incorporation) (Commissi |
|
| February 21, 2025 |
Exhibit 99.1 NEWS RELEASE DuPont Announces Election of Kurt McMaken to Board of Directors WILMINGTON, Del., Feb. 21, 2025 – DuPont (NYSE: DD) today announced the appointment of Kurt McMaken to its Board of Directors, effective immediately. Mr. McMaken will serve on the Audit committee and Nomination and Governance committee. "We are pleased to welcome Kurt to DuPont's Board of Directors,” said DuP |
|
| February 14, 2025 |
DuPont de Nemours, Inc. EXHIBIT 21 SUBSIDIARIES OF THE REGISTRANT DuPont de Nemours, Inc. EXHIBIT 21 SUBSIDIARIES OF THE REGISTRANT Set forth below are certain subsidiaries of DuPont de Nemours, Inc. Organized Under Laws Of Name Registrant - DuPont de Nemours, Inc. United States CUPOSIT Electronic Materials Zhangjiagang Co., Ltd. China DDP Speciality Products India Private Limited India DDP Specialty Electronic Materials US 9, LLC United States DDP Specialty Ele |
|
| February 14, 2025 |
DUPONT DE NEMOURS, INC. INSIDER TRADING POLICY (Effective as of December 17, 2024) EXHIBIT 19 DUPONT DE NEMOURS, INC. INSIDER TRADING POLICY (Effective as of December 17, 2024) This Insider Trading Policy provides the standards of DuPont de Nemours, Inc. (the “Company”) on trading the Company’s securities, or securities of other publicly-traded companies, while in possession of confidential information. This Policy is divided into three parts as follows: •Part 1 prohibits tradin |
|
| February 14, 2025 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-38196 DUPONT DE NEMOURS, INC. (Exact name of re |
|
| February 11, 2025 |
DuPont Reports Fourth Quarter and Full Year 2024 Results; Initiates 2025 Financial Guidance Exhibit 99.1 DuPont Reports Fourth Quarter and Full Year 2024 Results; Initiates 2025 Financial Guidance Fourth Quarter 2024 Highlights •Net Sales of $3.1 billion increased 7%; organic sales increased 7% versus year-ago period •GAAP Loss from continuing operations of $(61) million, operating EBITDA of $807 million •GAAP EPS from continuing operations of $(0.17); adjusted EPS of $1.13 •Cash provide |
|
| February 11, 2025 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 11, 2025 DuPont de Nemours, Inc. (Exact name of registrant as specified in its charter) Delaware 001-38196 81-1224539 (State or other jurisdiction of incorporation) (Commissi |
|
| November 12, 2024 |
SC 13G/A 1 SEC13GFiling.htm SEC SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1 )* DUPONT DE NEMOURS, INC. (Name of Issuer) Common Stock (Title of Class of Securities) 26614N102 (CUSIP Number) September 30, 2024 (Date of Event Which Requires Filing of this Statement) Check the appropriate b |
|
| November 5, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-38196 DUPONT DE NEMOURS, INC. (Exact name of registrant |
|
| November 5, 2024 |
DuPont Reports Third Quarter 2024 Results Exhibit 99.1 DuPont Reports Third Quarter 2024 Results •Net Sales of $3.2 billion increased 4%; organic sales increased 3% versus year-ago period •GAAP Income from continuing operations of $480 million; operating EBITDA of $857 million •GAAP EPS from continuing operations of $1.13; adjusted EPS of $1.18 •Cash provided by operating activities from continuing operations of $737 million; transaction- |
|
| November 5, 2024 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 5, 2024 DuPont de Nemours, Inc. (Exact name of registrant as specified in its charter) Delaware 001-38196 81-1224539 (State or other jurisdiction of incorporation) (Commissio |
|
| August 12, 2024 |
As filed with the Securities and Exchange Commission on August 12, 2024 Table of Contents As filed with the Securities and Exchange Commission on August 12, 2024 Registration No. |
|
| August 12, 2024 |
Statement of Eligibility on Form T-1 of trustee under the Indenture. Exhibit 25.1 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM T-1 STATEMENT OF ELIGIBILITY UNDER THE TRUST INDENTURE ACT OF 1939 OF A CORPORATION DESIGNATED TO ACT AS TRUSTEE ☐ Check if an Application to Determine Eligibility of a Trustee Pursuant to Section 305(b)(2) U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION (Exact name of Trustee as specified in its charter) 91-1821036 I.R.S. E |
|
| August 12, 2024 |
Exhibit 107 Calculation of Filing Fee Table Form S-3 (Form Type) DuPont de Nemours, Inc. |
|
| July 31, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-38196 DUPONT DE NEMOURS, INC. (Exact name of registrant as sp |
|
| July 31, 2024 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 31, 2024 DuPont de Nemours, Inc. (Exact name of registrant as specified in its charter) Delaware 001-38196 81-1224539 (State or other jurisdiction of incorporation) (Commission f |
|
| July 31, 2024 |
DuPont Reports Second Quarter 2024 Results EX-99.1 2 exhibit991enrschedules-2q24.htm EX-99.1 Exhibit 99.1 DuPont Reports Second Quarter 2024 Results •Net Sales of $3.2 billion increased 2%; organic sales flat versus year-ago period •GAAP Income from continuing operations of $176 million; operating EBITDA of $798 million •GAAP EPS from continuing operations of $0.40; adjusted EPS of $0.97 •Cash provided by operating activities from continui |
|
| June 27, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 27, 2024 DuPont de Nemours, Inc. (Exact name of registrant as specified in its charter) Delaware 001-38196 81-1224539 (State or other jurisdiction of incorporation) (Commission f |
|
| June 13, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 11-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 11-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR o TRANSITION REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-38196 A. |
|
| June 7, 2024 |
Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 7, 2024 (June 5, 2024) DuPont de Nemours, Inc. (Exact name of registrant as specified in its charter) Delaware 001-38196 81-1224539 (State or other jurisdiction of incorporation) |
|
| June 5, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 5, 2024 DuPont de Nemours, Inc. (Exact name of registrant as specified in its charter) Delaware 001-38196 81-1224539 (State or other jurisdiction of incorporation) (Commission fi |
|
| May 30, 2024 |
Exhibit 1.01 DuPont de Nemours, Inc. Conflict Minerals Report BACKGROUND This Conflict Minerals Report (this “Report”) of DuPont de Nemours, Inc. (“DuPont” or the “Company”), provides information with respect to products for which Conflict Minerals are “necessary to the functionality or production” that were manufactured by or contract manufactured for the Company and its consolidated subsidiaries |
|
| May 30, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM SD Specialized Disclosure Report DuPont de Nemours, Inc. (Exact name of registrant as specified in its charter) Delaware 001-38196 81-1224539 (State or other jurisdiction of incorporation) (Commission file number) (IRS Employer Identification No.) 974 Centre Road, Building 730 Wilmington, DE 19805 (Address of principal ex |
|
| May 23, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE (RULE 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as pe |
|
| May 22, 2024 |
Exhibit 99.1 DuPont Announces Leadership Transition Ed Breen to Transition to Executive Chair Role; Lori Koch Named Chief Executive Officer; Antonella Franzen Named Chief Financial Officer WILMINGTON, Del., May 22, 2024 - DuPont (NYSE: DD) today announced that its Board of Directors has selected Lori D. Koch, DuPont’s Chief Financial Officer, to succeed Edward D. Breen as the company’s Chief Execu |
|
| May 22, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 22, 2024 DuPont de Nemours, Inc. (Exact name of registrant as specified in its charter) Delaware 001-38196 81-1224539 (State or other jurisdiction of incorporation) (Commission fi |
|
| May 22, 2024 |
DuPont Announces Plan to Separate into Three Independent, Publicly Traded Companies Exhibit 99.2 DuPont Announces Plan to Separate into Three Independent, Publicly Traded Companies • Tax-free separations create independent, focused Electronics and Water companies that are global leaders in their respective industries • New DuPont will remain a premier diversified industrial company with industry-leading brands and solutions • Reaffirms second quarter and full year 2024 net sales, |
|
| May 22, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE (RULE 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as pe |
|
| May 1, 2024 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 1, 2024 DuPont de Nemours, Inc. (Exact name of registrant as specified in its charter) Delaware 001-38196 81-1224539 (State or other jurisdiction of incorporation) (Commission fil |
|
| May 1, 2024 |
DuPont Reports First Quarter 2024 Results Exhibit 99.1 DuPont Reports First Quarter 2024 Results •Net Sales of $2.9 billion decreased 3%; organic sales decreased 6% versus year-ago period •GAAP Income from continuing operations of $183 million; operating EBITDA of $682 million •GAAP EPS from continuing operations of $0.41; adjusted EPS of $0.79 •Cash provided by operating activities from continuing operations of $493 million; adjusted fre |
|
| May 1, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-38196 DUPONT DE NEMOURS, INC. (Exact name of registrant as s |
|
| April 5, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE (RULE 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as p |
|
| April 5, 2024 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE (RULE 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Com |
|
| February 15, 2024 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-38196 DUPONT DE NEMOURS, INC. (Exact name of re |
|
| February 15, 2024 |
DuPont de Nemours, Inc. EXHIBIT 21 SUBSIDIARIES OF THE REGISTRANT DuPont de Nemours, Inc. EXHIBIT 21 SUBSIDIARIES OF THE REGISTRANT Set forth below are certain subsidiaries of DuPont de Nemours, Inc. Organized Under Laws Of Name Registrant - DuPont de Nemours, Inc. Delaware 3313045 Nova Scotia Company Canada CUPOSIT Electronic Materials Zhangjiagang Co., Ltd. China DDP SpecialityProducts India Private Limited India DDP Specialty Electronic Materials US 9, LLC De |
|
| February 15, 2024 |
DuPont de Nemours, Inc. Incentive Compensation Clawback Policy (Effective October 2, 2023) EXHIBIT 97 DuPont de Nemours, Inc. Incentive Compensation Clawback Policy (Effective October 2, 2023) This Incentive Compensation Policy (“Policy”) covers each current and former employee of DuPont de Nemours, Inc. (the “Company”) or an “Affiliate” (within the meaning of the Company’s Omnibus Incentive Plan (the “Plan”)) who is or was, as the case may be, the recipient of cash-based or equity-base |
|
| February 13, 2024 |
DOW / Dow Inc. / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SC 13G/A 1 tv0055-dupontdenemoursinc.htm SCHEDULE 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 7)* Name of issuer: DuPont de Nemours Inc Title of Class of Securities: Common Stock CUSIP Number: 26614N102 Date of Event Which Requires Filing of this Statement: December 29, 2023 Check the appropriate box to desi |
|
| February 9, 2024 |
DOW / Dow Inc. / MASSACHUSETTS FINANCIAL SERVICES CO /MA/ - SEC SCHEDULE 13G Passive Investment SC 13G 1 SEC13GFiling.htm SEC SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* DUPONT DE NEMOURS, INC. (Name of Issuer) Common Stock (Title of Class of Securities) 26614N102 (CUSIP Number) December 29, 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to |
|
| February 6, 2024 |
Exhibit 99.1 DuPont Reports Fourth Quarter and Full Year 2023 Results Announces New Share Repurchase Authorization and Quarterly Dividend Increase Fourth Quarter 2023 Highlights •Net Sales of $2.9 billion decreased 7%; organic sales decreased 10% versus year-ago period •GAAP Loss from continuing operations of $(300) million, includes ~$800 million non-cash goodwill impairment charge; operating EBI |
|
| February 6, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 6, 2024 DuPont de Nemours, Inc. (Exact name of registrant as specified in its charter) Delaware 001-38196 81-1224539 (State or other jurisdiction of incorporation) (Commissio |
|
| January 24, 2024 |
Exhibit 99.1 DuPont Announces Preliminary Fourth Quarter and Full Year 2023 Results and Provides Initial First Quarter 2024 Outlook Schedules Quarterly Earnings Conference Call for February 6, 2024 WILMINGTON, Del., Jan. 24, 2024 - DuPont (NYSE: DD) today announced preliminary financial results(1) for the fourth quarter and full year ended December 31, 2023, provided an initial outlook for the fir |
|
| January 24, 2024 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 24, 2024 DuPont de Nemours, Inc. (Exact name of registrant as specified in its charter) Delaware 001-38196 81-1224539 (State or other jurisdiction of incorporation) (Commissio |
|
| December 8, 2023 |
DOW / Dow Inc / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SC 13G/A 1 tv0005-dupontdenemoursinc.htm SCHEDULE 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 6)* Name of issuer: DuPont de Nemours Inc Title of Class of Securities: Common Stock CUSIP Number: 26614N102 Date of Event Which Requires Filing of this Statement: November 30, 2023 Check the appropriate box to desi |
|
| November 2, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-38196 DUPONT DE NEMOURS, INC. (Exact name of registrant |
|
| November 1, 2023 |
DuPont Reports Third Quarter 2023 Results Exhibit 99.1 DuPont Reports Third Quarter 2023 Results Third Quarter 2023 Highlights •Net Sales of $3.1 billion decreased 8%; organic sales decreased 10% versus year-ago period •GAAP Income from continuing operations of $291 million; operating EBITDA of $775 million •GAAP EPS from continuing operations of $0.62; adjusted EPS of $0.92 •Cash provided by operating activities from continuing operation |
|
| November 1, 2023 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 1, 2023 DuPont de Nemours, Inc. (Exact name of registrant as specified in its charter) Delaware 001-38196 81-1224539 (State or other jurisdiction of incorporation) (Commissio |
|
| August 3, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-38196 DUPONT DE NEMOURS, INC. (Exact name of registrant as sp |
|
| August 2, 2023 |
DuPont Reports Second Quarter 2023 Results Exhibit 99.1 DuPont Reports Second Quarter 2023 Results Second Quarter 2023 Highlights •Net Sales of $3.1 billion decreased 7%; organic sales decreased 4% versus year-ago period •GAAP Income from continuing operations of $269 million; operating EBITDA of $738 million •GAAP EPS from continuing operations of $0.55; adjusted EPS of $0.85 •Cash provided by operating activities from continuing operatio |
|
| August 2, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 2, 2023 DuPont de Nemours, Inc. (Exact name of registrant as specified in its charter) Delaware 001-38196 81-1224539 (State or other jurisdiction of incorporation) (Commission |
|
| June 30, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 30, 2023 DuPont de Nemours, Inc. (Exact name of registrant as specified in its charter) Delaware 001-38196 81-1224539 (State or other jurisdiction of incorporation) (Commission f |
|
| June 30, 2023 |
UNITED STATES DISTRICT COURT FOR THE DISTRICT OF SOUTH CAROLINA CHARLESTON DIVISION Exhibit 2.1 UNITED STATES DISTRICT COURT FOR THE DISTRICT OF SOUTH CAROLINA CHARLESTON DIVISION ) IN RE: AQUEOUS FILM-FORMING ) MDL No. 2:18-mn-2873 FOAMS PRODUCTS LIABILITY ) LITIGATION ) ) CLASS ACTION SETTLEMENT AGREEMENT This Settlement Agreement (including its Exhibits) is entered into, subject to Preliminary and Final Approval of the Court, as of June 30, 2023 (the “Settlement Date”), by and |
|
| June 13, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 11-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 11-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR o TRANSITION REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-38196 A. |
|
| June 2, 2023 |
Chemours, DuPont, and Corteva Reach Comprehensive PFAS Settlement with U.S. Water Systems Chemours, DuPont, and Corteva Reach Comprehensive PFAS Settlement with U.S. Water Systems WILMINGTON, Del., June 2, 2023 – The Chemours Company (NYSE: CC), DuPont de Nemours, Inc. (NYSE: DD) and Corteva, Inc. (NYSE: CTVA) (the “companies”) today announced they have reached an agreement in principle to comprehensively resolve all PFAS-related drinking water claims of a defined class of public water |
|
| June 2, 2023 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 2, 2023 (June 1, 2023) DuPont de Nemours, Inc. (Exact name of registrant as specified in its charter) Delaware 001-38196 81-1224539 (State or other jurisdiction of incorporation) |
|
| May 30, 2023 |
Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 30, 2023 (May 24, 2023) DuPont de Nemours, Inc. (Exact name of registrant as specified in its charter) Delaware 001-38196 81-1224539 (State or other jurisdiction of incorporation) |
|
| May 25, 2023 |
EX-1.01 2 a123122sdex-101.htm EX-1.01 Exhibit 1.01 DuPont de Nemours, Inc. Conflict Minerals Report BACKGROUND This Conflict Minerals Report (this “Report”) of DuPont de Nemours, Inc. (“DuPont” or the “Company”), is being filed pursuant to Rule 13p-1 under the Securities Exchange Act (17 CFR 240.13p-1) for the reporting period from January 1, 2022 to December 31, 2022. This Report provides informa |
|
| May 25, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM SD Specialized Disclosure Report DuPont de Nemours, Inc. (Exact name of registrant as specified in its charter) Delaware 001-38196 81-1224539 (State or other jurisdiction of incorporation) (Commission file number) (IRS Employer Identification No.) 974 Centre Road, Building 730 Wilmington, DE 19805 (Address of principal ex |
|
| May 3, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-38196 DUPONT DE NEMOURS, INC. (Exact name of registrant as s |
|
| May 2, 2023 |
DuPont Reports First Quarter 2023 Results Exhibit 99.1 DuPont Reports First Quarter 2023 Results •Net Sales of $3.0 billion decreased 8%; organic sales decreased 3% versus year-ago period •GAAP Income from continuing operations of $273 million; operating EBITDA of $714 million •GAAP EPS from continuing operations of $0.58; adjusted EPS of $0.84 •Operating cash flow of $343 million; adjusted free cash flow of $102 million WILMINGTON, Del., |
|
| May 2, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 2, 2023 DuPont de Nemours, Inc. (Exact name of registrant as specified in its charter) Delaware 001-38196 81-1224539 (State or other jurisdiction of incorporation) (Commission fil |
|
| April 6, 2023 |
DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE (RULE 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Onl |
|
| April 6, 2023 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE (RULE 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Com |
|
| March 30, 2023 |
Exhibit 3.1 AMENDED AND RESTATED BYLAWS OF DUPONT DE NEMOURS, INC. (a Delaware corporation) EFFECTIVE AS OF MARCH 29, 2023 TABLE OF CONTENTS ARTICLE I CAPITAL STOCK 4 1.1 Certificates 4 1.2 Record Ownership 4 1.3 Transfer of Record Ownership 4 1.4 Lost Certificates 5 1.5 Transfer Agents; Registrars; Rules Respecting Certificates 5 1.6 Record Date 5 ARTICLE II MEETINGS OF STOCKHOLDERS 5 2.1 Annual |
|
| March 30, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 30, 2023 (March 29, 2023) DuPont de Nemours, Inc. (Exact name of registrant as specified in its charter) Delaware 001-38196 81-1224539 (State or other jurisdiction of incorporat |
|
| March 20, 2023 |
March 20, 2023 United States Securities and Exchange Commission Division of Corporation Finance Office of Industrial Applications and Services Washington, D. |
|
| February 15, 2023 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-38196 DUPONT DE NEMOURS, INC. (Exact name of re |
|
| February 15, 2023 |
DuPont de Nemours, Inc. EXHIBIT 21 SUBSIDIARIES OF THE REGISTRANT DuPont de Nemours, Inc. EXHIBIT 21 SUBSIDIARIES OF THE REGISTRANT Set forth below are certain subsidiaries of DuPont de Nemours, Inc. Organized Under Laws Of Name 3313045 Nova Scotia Company Canada CUPOSIT Electronic Materials Zhangjiagang Co., Ltd. China DDP Specialty Electronic Materials US 9, LLC Delaware DDP Specialty Electronic Materials US, LLC Delaware DDP Specialty Products Japan K.K. Japa |
|
| February 9, 2023 |
DOW / Dow Chemical Co. (The) / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 5)* Name of issuer: DuPont de Nemours Inc. Title of Class of Securities: Common Stock CUSIP Number: 26614N102 Date of Event Which Requires Filing of this Statement: December 30, 2022 Check the appropriate box to designate the rule pursuant to which this Schedule is filed |
|
| February 7, 2023 |
Exhibit 10.1 February 6, 2023 By Email Edward D. Breen Re: Continued Employment Dear Ed: We take pleasure in confirming for you in this letter agreement (this “Letter Agreement”) our intent for your continued employment as Chief Executive Officer (“CEO”) of DuPont de Nemours, Inc. (the “Company”) upon the expiration of your current amended and restated employment agreement with the Company dated a |
|
| February 7, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 7, 2023 (February 6, 2023) DuPont de Nemours, Inc. (Exact name of registrant as specified in its charter) Delaware 001-38196 81-1224539 (State or other jurisdiction of incorp |
|
| February 7, 2023 |
Exhibit 99.1 DuPont Reports Fourth Quarter and Full Year 2022 Results Announces First Quarter 2023 Dividend Increase of 9 Percent Fourth Quarter 2022 Highlights •4Q Net Sales of $3.1 billion decreased 4%; organic sales increased 5% versus year-ago period •4Q GAAP Income from continuing operations of $105 million; operating EBITDA of $758 million •4Q GAAP EPS from continuing operations of $0.20; ad |
|
| November 8, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 8, 2022 DuPont de Nemours, Inc. (Exact name of registrant as specified in its charter) Delaware 001-38196 81-1224539 (State or other jurisdiction of incorporation) (Commissio |
|
| November 8, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-38196 DUPONT DE NEMOURS, INC. (Exact name of registrant |
|
| November 8, 2022 |
Exhibit 99.1 DuPont Reports Third Quarter 2022 Results Announces Approval of $5.0 Billion Share Repurchase Authorization Third Quarter 2022 Highlights •3Q Net Sales of $3.3 billion increased 4%; organic sales increased 11% versus year-ago period •3Q GAAP Income from continuing operations of $359 million; operating EBITDA of $856 million increased 5% versus year-ago period •Operating EBITDA margin |
|
| November 2, 2022 |
UNAUDITED PRO FORMA CONSOLIDATED FINANCIAL STATEMENTS Exhibit 99.2 UNAUDITED PRO FORMA CONSOLIDATED FINANCIAL STATEMENTS Overview On November 1, 2022, DuPont de Nemours, Inc. (?DuPont?) completed the previously announced divestiture of the majority of the Company?s historic Mobility & Materials segment, including the Engineering Polymers business line and select product lines within the Performance Resins and Advanced Solutions business lines (the ?M |
|
| November 2, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 2, 2022 (November 1, 2022) DuPont de Nemours, Inc. (Exact name of registrant as specified in its charter) Delaware 001-38196 81-1224539 (State or other jurisdiction of incorp |
|
| November 2, 2022 |
DuPont Completes M&M Divestiture to Celanese 99.1 NEWS RELEASE DuPont Completes M&M Divestiture to Celanese WILMINGTON, Del., November 1, 2022 ? DuPont (NYSE:DD) today completed the previously announced divestiture of the majority of its former Mobility & Materials segment (the ?M&M Business? or the ?M&M Divestiture?) to Celanese for a purchase price of $11 billion in cash, subject to customary transaction adjustments in accordance with the |
|
| October 20, 2022 |
Exhibit 3.1 SIXTH AMENDED AND RESTATED BYLAWS OF DUPONT DE NEMOURS, INC. (a Delaware corporation) EFFECTIVE AS OF OCTOBER 19, 2022 TABLE OF CONTENTS ARTICLE I CAPITAL STOCK 4 1.1 Certificates 4 1.2 Record Ownership 4 1.3 Transfer of Record Ownership 4 1.4 Lost Certificates 4 1.5 Transfer Agents; Registrars; Rules Respecting Certificates 5 1.6 Record Date 5 ARTICLE II MEETINGS OF STOCKHOLDERS 5 2.1 |
|
| October 20, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 20, 2022 ( October 19, 2022) DuPont de Nemours, Inc. (Exact name of registrant as specified in its charter) Delaware 001-38196 81-1224539 (State or other jurisdiction of incor |
|
| August 4, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-38196 DUPONT DE NEMOURS, INC. (Exact name of registrant as sp |
|
| August 2, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 2, 2022 DuPont de Nemours, Inc. (Exact name of registrant as specified in its charter) Delaware 001-38196 81-1224539 (State or other jurisdiction of incorporation) (Commission |
|
| August 2, 2022 |
DuPont Reports Second Quarter 2022 Results Exhibit 99.1 DuPont Reports Second Quarter 2022 Results ?2Q22 Net Sales of $3.3 billion, increased 7%; organic sales increased 9% versus year-ago period ?2Q22 GAAP Income from continuing operations of $365 million; operating EBITDA of $829 million increased 6% versus year-ago period; consistent operating EBITDA margin on year-over-year and sequential basis ?2Q22 GAAP EPS from continuing operations |
|
| July 11, 2022 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 11, 2022 DuPont de Nemours, Inc. (Exact name of registrant as specified in its charter) Delaware 001-38196 81-1224539 (State or other jurisdiction of incorporation) (Commission f |
|
| July 11, 2022 |
Exhibit 99.1 Unaudited Revised Combined Statements of Operations and Historical Segment Information On February 17, 2022, DuPont entered into a Transaction Agreement (the "Transaction Agreement") with Celanese Corporation ("Celanese") to divest a majority of the historic Mobility & Materials segment, including the Engineering Polymers business line and select product lines within the Advanced Solu |
|
| June 15, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 11-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 11-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 OR o TRANSITION REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-38196 A. |
|
| May 31, 2022 |
Exhibit 99.1 NEWS RELEASE DuPont Announces Election of Kristina M. Johnson to Board of Directors WILMINGTON, Del., May 26, 2022 ? DuPont (NYSE: DD) today announced that Kristina M. Johnson has been elected to its Board of Directors. Dr. Johnson was elected as a new director at the Company?s 2022 Annual Meeting of Shareholders earlier today. ?We?re excited to welcome Kristina Johnson to DuPont?s Bo |
|
| May 31, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 31, 2022 (May 26, 2022) DuPont de Nemours, Inc. (Exact name of registrant as specified in its charter) Delaware 001-38196 81-1224539 (State or other jurisdiction of incorporation) |
|
| May 26, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM SD Specialized Disclosure Report DuPont de Nemours, Inc. (Exact name of registrant as specified in its charter) Delaware 001-38196 81-1224539 (State or other jurisdiction of incorporation) (Commission file number) (IRS Employer Identification No.) 974 Centre Road, Building 730 Wilmington, DE 19805 (Address of principal ex |
|
| May 26, 2022 |
EX-1.01 2 a123121sdex-101.htm EX-1.01 Exhibit 1.01 DuPont de Nemours, Inc. Conflict Minerals Report BACKGROUND This Conflict Minerals Report (this “Report”) of DuPont de Nemours, Inc. (“DuPont” or the “Company”), is being filed pursuant to Rule 13p-1 under the Securities Exchange Act (17 CFR 240.13p-1) for the reporting period from January 1, 2021 to December 31, 2021. This Report provides informa |
|
| May 6, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-38196 DUPONT DE NEMOURS, INC. (Exact name of registrant as s |
|
| May 3, 2022 |
DuPont Reports First Quarter 2022 Results Exhibit 99.1 DuPont Reports First Quarter 2022 Results ?1Q22 Net Sales of $3.3 billion, increased 9%; organic sales increased 9% versus year-ago period ?1Q22 GAAP Income from continuing operations of $232 million; operating EBITDA of $818 million increased 2% versus year-ago period ?1Q22 GAAP EPS from continuing operations of $0.42; adjusted EPS of $0.82 increased 19% versus year-ago period ?$544 |
|
| May 3, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 3, 2022 DuPont de Nemours, Inc. (Exact name of registrant as specified in its charter) Delaware 001-38196 81-1224539 (State or other jurisdiction of incorporation) (Commission fil |
|
| April 8, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE (RULE 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as pe |
|
| April 8, 2022 |
DEF 14A 1 d298914ddef14a.htm DEF 14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE (RULE 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statemen |
|
| February 22, 2022 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 22, 2022 (February 17, 2022) DuPont de Nemours, Inc. (Exact name of registrant as specified in its charter) Delaware 001-38196 81-1224539 (State or other jurisdiction of inco |
|
| February 22, 2022 |
Exhibit 2.1 EXECUTION VERSION TRANSACTION AGREEMENT BY AND AMONG DUPONT DE NEMOURS, INC., DUPONT E&I HOLDING, INC. AND CELANESE CORPORATION Dated as of February 17, 2022 TABLE OF CONTENTS ARTICLE I DEFINITIONS Section 1.1 Definitions 2 Section 1.2 Defined Terms 31 ARTICLE II CLOSING Section 2.1 Closing 38 Section 2.2 Closing Date 38 Section 2.3 Purchase Price Calculation and Purchase Price Adjustm |
|
| February 18, 2022 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 17, 2022 DuPont de Nemours, Inc. (Exact name of registrant as specified in its charter) Delaware 001-38196 81-1224539 (State or other jurisdiction of incorporation) (Commissi |
|
| February 18, 2022 |
DuPont Announces Agreement to Divest Majority of Mobility & Materials Segment to Celanese Exhibit 99.1 DuPont Announces Agreement to Divest Majority of Mobility & Materials Segment to Celanese ? To maximize shareholder value, DuPont will execute the previously announced M&M divestiture in two transactions; including greater than 80% to be divested to Celanese ? Definitive agreement with Celanese to divest the Engineering Polymers business line and select product lines within the Perfor |
|
| February 11, 2022 |
DuPont de Nemours, Inc. EXHIBIT 21 SUBSIDIARIES OF THE REGISTRANT DuPont de Nemours, Inc. EXHIBIT 21 SUBSIDIARIES OF THE REGISTRANT Set forth below are certain subsidiaries of DuPont de Nemours, Inc. Organized Under Laws Of Name 3313045 Nova Scotia Company Canada CUPOSIT Electronic Materials (Zhangjiagang) Co., Ltd. China DDP Specialty Electronic Materials US 9, LLC Delaware DDP Specialty Electronic Materials US, LLC Delaware DDP Specialty Products Japan KK Japa |
|
| February 11, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-38196 DUPONT DE NEMOURS, INC. (Exact name of registrant as specif |
|
| February 9, 2022 |
DOW / Dow Chemical Co. (The) / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 4)* Name of issuer: DuPont de Nemours Inc. Title of Class of Securities: Common Stock CUSIP Number: 26614N102 Date of Event Which Requires Filing of this Statement: December 31, 2021 Check the appropriate box to designate the rule pursuant to which this Schedule is filed |
|
| February 8, 2022 |
Exhibit 99.1 DuPont Reports Fourth Quarter and Full Year 2021 Results Announces 10 Percent Increase to First Quarter Regular Dividend and Board Approval of $1.0 Billion Share Buyback Program ?4Q21 Net Sales of $4.3 billion, up 14 percent; organic sales up 13 percent versus year-ago period ?4Q21 GAAP Income from continuing operations of $266 million; operating EBITDA of $973 million ?4Q21 GAAP EPS |
|
| February 8, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 8, 2022 DuPont de Nemours, Inc. (Exact name of registrant as specified in its charter) Delaware 001-38196 81-1224539 (State or other jurisdiction of incorporation) (Commissio |
|
| January 20, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 20, 2022 DuPont de Nemours, Inc. (Exact name of registrant as specified in its charter) Delaware 001-38196 81-1224539 (State or other jurisdiction of incorporation) (Commissio |
|
| November 3, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-38196 DUPONT DE NEMOURS, INC. (Exact name of registrant |
|
| November 2, 2021 |
DuPont Reports Third Quarter 2021 Results Exhibit 99.1 DuPont Reports Third Quarter 2021 Results ?3Q21 GAAP EPS from continuing operations of $0.80; adjusted EPS of $1.15 ?3Q21 Net Sales of $4.3 billion, up 18 percent; organic sales up 16 percent versus the year-ago period on 10 percent volume improvement and 6 percent pricing gains ?3Q21 GAAP Income from continuing operations of $433 million; operating EBITDA of $1.09 billion, up 20 perc |
|
| November 2, 2021 |
DuPont Announces Strategic Actions to Enhance Portfolio for Near and Long-term Value Creation Exhibit 99.2 DuPont Announces Strategic Actions to Enhance Portfolio for Near and Long-term Value Creation ?Acquisition of Rogers Corporation will expand DuPont?s leadership position in advanced materials for high-growth secular end-markets, including electric vehicles, advanced driver assistance systems (ADAS), 5G telecommunications and clean energy ?Announces intent to divest a substantial porti |
|
| November 2, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 2, 2021 DuPont de Nemours, Inc. (Exact name of registrant as specified in its charter) Delaware 001-38196 81-1224539 (State or other jurisdiction of incorporation) (Commissio |
|
| August 11, 2021 |
As filed with the Securities and Exchange Commission on August 11, 2021 Table of Contents As filed with the Securities and Exchange Commission on August 11, 2021 Registration No. |
|
| August 11, 2021 |
Statement of Eligibility on Form T-1 of trustee under the Indenture. Exhibit 25.1 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM T-1 STATEMENT OF ELIGIBILITY UNDER THE TRUST INDENTURE ACT OF 1939 OF A CORPORATION DESIGNATED TO ACT AS TRUSTEE ? Check if an Application to Determine Eligibility of a Trustee Pursuant to Section 305(b)(2) U.S. BANK NATIONAL ASSOCIATION (Exact name of Trustee as specified in its charter) 31-0841368 I.R.S. Employer Identif |
|
| August 4, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-38196 DUPONT DE NEMOURS, INC. (Exact name of registrant as sp |
|
| August 4, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 4, 2021 (August 3, 2021) DuPont de Nemours, Inc. (Exact name of registrant as specified in its charter) Delaware 001-38196 81-1224539 (State or other jurisdiction of incorporat |
|
| August 3, 2021 |
DuPont Reports Second Quarter 2021 Results Exhibit 99.1 DuPont Reports Second Quarter 2021 Results ?2Q21 GAAP EPS from continuing operations of $1.04; adjusted EPS of $1.06 ?2Q21 Net Sales of $4.1 billion, up 26 percent; organic sales up 23 percent versus the year-ago period ?2Q21 GAAP Income from continuing operations of $564 million; operating EBITDA of $1.06 billion, up 53 percent versus the year-ago period; operating EBITDA margin expa |
|
| August 3, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 3, 2021 DuPont de Nemours, Inc. (Exact name of registrant as specified in its charter) Delaware 001-38196 81-1224539 (State or other jurisdiction of incorporation) (Commission |
|
| June 17, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 11-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 11-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 OR o TRANSITION REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-38196 A. |
|
| June 3, 2021 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 3, 2021 DuPont de Nemours, Inc. (Exact name of registrant as specified in its charter) Delaware 001-38196 81-1224539 (State or other jurisdiction of incorporation) (Commission fi |
|
| June 3, 2021 |
Exhibit 99.1 DuPont de Nemours, Inc. EXPLANATORY NOTE Throughout this Current Report on Form 8-K, except as otherwise indicated by the context, the terms ?DuPont? or ?Company? used herein mean DuPont de Nemours, Inc. and its consolidated subsidiaries. This Current Report on Form 8-K (including this Exhibit 99.1, the ?Form 8-K?), is being filed to recast certain financial information included in Du |
|
| May 27, 2021 |
Exhibit 1.01 DuPont de Nemours, Inc. Conflict Minerals Report BACKGROUND This Conflict Minerals Report (this ?Report?) of DuPont de Nemours, Inc. (?DuPont? or the ?Company?), is being filed pursuant to Rule 13p-1 under the Securities Exchange Act (17 CFR 240.13p-1) for the reporting period from January 1, 2020 to December 31, 2020. This Report provides information with respect to the products manu |
|
| May 27, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM SD Specialized Disclosure Report DuPont de Nemours, Inc. (Exact name of registrant as specified in its charter) Delaware 001-38196 81-1224539 (State or other jurisdiction of incorporation) (Commission file number) (IRS Employer Identification No.) 974 Centre Road, Building 730 Wilmington, DE 19805 (Address of principal ex |
|
| May 4, 2021 |
DuPont Reports First Quarter 2021 Results EX-99.1 2 exhibit991enrschedules-1q21.htm EX-99.1 Exhibit 99.1 DuPont Reports First Quarter 2021 Results •1Q21 GAAP EPS from continuing operations of $0.89; adjusted EPS of $0.91 •1Q21 Net Sales of $4.0 billion, up 8 percent; organic sales up 7 percent versus the year-ago period •1Q21 GAAP Income from continuing operations of $541 million; operating EBITDA of $1.05 billion, up 15 percent versus th |
|
| May 4, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 4, 2021 DuPont de Nemours, Inc. (Exact name of registrant as specified in its charter) Delaware 001-38196 81-1224539 (State or other jurisdiction of incorporation) (Commission fil |
|
| May 4, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-38196 DUPONT DE NEMOURS, INC. (Exact name of registrant as s |
|
| April 30, 2021 |
Exhibit 3.2 FIFTH AMENDED AND RESTATED BYLAWS OF DUPONT DE NEMOURS, INC. (a Delaware corporation) EFFECTIVE AS OF APRIL 28, 2021 Exhibit 3.2 TABLE OF CONTENTS Article I CAPITAL STOCK 4 1.1 Certificates 4 1.2 Record Ownership 4 1.3 Transfer of Record Ownership 4 1.4 Lost Certificates 4 1.5 Transfer Agents; Registrars; Rules Respecting Certificates 5 1.6 Record Date 5 Article II MEETINGS OF STOCKHOL |
|
| April 30, 2021 |
Exhibit 99.1 NEWS RELEASE DuPont Appoints Deanna M. Mulligan to Board of Directors WILMINGTON, Del., April, 30, 2021 ? DuPont (NYSE: DD) today announced the appointment of Deanna M. Mulligan to its Board of Directors, effective April 27, 2021. Following appointment, Ms. Mulligan was elected to the Board at the Company?s Annual Meeting of Stockholders on April 28, 2021. ?We are pleased to welcome D |
|
| April 30, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 30, 2021 (April 27, 2021) DuPont de Nemours, Inc. (Exact name of registrant as specified in its charter) Delaware 001-38196 81-1224539 (State or other jurisdiction of incorporat |
|
| April 30, 2021 |
Exhibit 3.1 THIRD AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF DUPONT DE NEMOURS, INC. DuPont de Nemours, Inc. (hereinafter called the ?Company?), a corporation organized and existing under the laws of the State of Delaware, does hereby certify as follows: FIRST: The original Certificate of Incorporation of the Company was filed with the Secretary of State of the State of Delaware on Decem |
|
| April 14, 2021 |
DEFA14A 1 d142004ddefa14a.htm DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as |
|
| April 13, 2021 |
PX14A6G 1 p413211px14a6g.htm 2150 Kittredge St. Suite 450 www.asyousow.org Berkeley, CA 94704 BUILDING A SAFE, JUST, AND SUSTAINABLE WORLD SINCE 1992 Notice of Exempt Solicitation Pursuant to Rule 14a-103 Name of the Registrant: DuPont de Nemours Inc (DD) Name of persons relying on exemption: As You Sow Address of persons relying on exemption: 2150 Kittredge St. Suite 450, Berkeley, CA 94704 Writt |
|
| March 17, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Defin |
|
| March 15, 2021 |
DuPont Ed Breen, Executive Chairman and Chief Executive Officer | J.P. Morgan Industrials Conference | March 15, 2021 Exhibit 99.1 1Q and FY 2021 Guidance All estimates exclude the Nutrition & Biosciences business which will be reflected as discontinued operations 2 (1) Change at the mid-point of the range versus prior year is based on revised, unaudited financial information included in DuPont?s |
|
| March 15, 2021 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 15, 2021 DuPont de Nemours, Inc. (Exact name of registrant as specified in its charter) Delaware 001-38196 81-1224539 (State or other jurisdiction of incorporation) (Commission |
|
| March 12, 2021 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14 |
|
| March 12, 2021 |
DEFA14A 1 d108785ddefa14a.htm DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as |
|
| March 2, 2021 |
PRE 14A 1 d108785dpre14a.htm PRE 14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confidential, for Use of the Com |
|
| February 24, 2021 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 24, 2021 DuPont de Nemours, Inc. (Exact name of registrant as specified in its charter) Delaware 001-38196 81-1224539 (State or other jurisdiction of incorporation) (Commissi |
|
| February 24, 2021 |
Exhibit 99.1 Unaudited Revised Combined Statements of Operations and Historical Segment Information On February 1, 2021, DuPont de Nemours, Inc. (?DuPont? or the ?Company?) completed the previously announced separation of its Nutrition & Biosciences business (?N&B Business?) in a Reverse Morris Trust transaction through the distribution to its stockholders of Nutrition & Biosciences, Inc. (?N&B?), |
|
| February 12, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-38196 DUPONT DE NEMOURS, INC. (Exact name of registrant as specif |
|
| February 12, 2021 |
EX-21.1 2 exhibit21123120.htm EX-21.1 DuPont de Nemours, Inc. EXHIBIT 21 SUBSIDIARIES OF THE REGISTRANT Set forth below are certain subsidiaries of DuPont de Nemours, Inc. Organized Under Laws Of Name CUPOSIT Electronic Materials Zhangjiagang Co., Ltd. China DACI Investments, LLC Delaware DDP Speciality Products India Private Limited India DDP Specialty Electronic Materials US 5, LLC Delaware DDP |
|
| February 10, 2021 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 3)* Name of issuer: DuPont de Nemours Inc. Title of Class of Securities: Common Stock CUSIP Number: 26614N102 Date of Event Which Requires Filing of this Statement: December 31, 2020 Check the appropriate box to designate the rule pursuant to which this Schedule is filed |
|
| February 9, 2021 |
DuPont Reports Fourth Quarter 2020 Results Exhibit 99.1 DuPont Reports Fourth Quarter 2020 Results •4Q20 GAAP EPS from continuing operations of $0.37; adjusted EPS of $0.95 •4Q20 Net Sales of $5.3 billion, up 1 percent; organic sales flat with the year-ago period •4Q20 GAAP Income from continuing operations of $279 million and Operating EBITDA of $1.3 billion •~$130 million in non-manufacturing costs savings in the quarter; delivered struc |
|
| February 9, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 9, 2021 DuPont de Nemours, Inc. (Exact name of registrant as specified in its charter) Delaware 001-38196 81-1224539 (State or other jurisdiction of incorporation) (Commissio |
|
| February 4, 2021 |
EX-99.1 Exhibit 99.1 NEWS RELEASE DuPont Announces Preliminary Results of Exchange Offer in Connection with IFF Transaction WILMINGTON, Del., Feb. 1, 2021 – DuPont (NYSE: DD) announced today the preliminary results of its exchange offer in connection with the previously announced separation of its nutrition and biosciences business (the “N&B Business”) and merger of Nutrition & Biosciences, Inc. ( |
|
| February 4, 2021 |
EX-2.4 Exhibit 2.4 EXECUTION COPY AMENDMENT NO. 2 TO THE SEPARATION AND DISTRIBUTION AGREEMENT This Amendment No. 2 (this “Second Amendment”) to the Separation and Distribution Agreement, dated as of December 15, 2019 (the “Original SDA”), as amended by that certain Amendment No. 1 to the Separation and Distribution Agreement, dated as of January 22, 2021 (the “Agreement”), is made as of February |
|
| February 4, 2021 |
EX-10.2 4 d11627dex102.htm EX-10.2 Exhibit 10.2 Execution Copy INTELLECTUAL PROPERTY CROSS-LICENSE AGREEMENT This INTELLECTUAL PROPERTY CROSS-LICENSE AGREEMENT (this “Agreement”), dated as of February 1, 2021 (the “Effective Date”), is entered into by and between Nutrition & Biosciences, Inc., a Delaware corporation (“Spinco”), the Spinco Licensors and the Spinco Licensees, on the one hand, and Du |
|
| February 4, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) February 4, 2021 (February 1, 2021) DuPont de Nemours, Inc. (Exact name of registrant as specified in its charter) Delaware 001-38196 81-1224539 (State or other jurisdiction of incorpo |
|
| February 4, 2021 |
UNAUDITED PRO FORMA CONSOLIDATED FINANCIAL STATEMENTS EX-99.3 Exhibit 99.3 UNAUDITED PRO FORMA CONSOLIDATED FINANCIAL STATEMENTS Overview On February 1, 2021, DuPont de Nemours, Inc. (“DuPont”) completed the previously announced separation of its Nutrition & Biosciences business (“N&B Business”) in a Reverse Morris Trust transaction through the distribution to its stockholders of Nutrition & Biosciences, Inc. (“N&B”), formed by DuPont as a wholly own |
|
| February 4, 2021 |
EX-10.1 Exhibit 10.1 EXECUTION COPY TAX MATTERS AGREEMENT BY AND AMONG DUPONT DE NEMOURS, INC., NUTRITION & BIOSCIENCES, INC. AND INTERNATIONAL FLAVOR & FRAGRANCES INC. FEBRUARY 1, 2021 TABLE OF CONTENTS Page SECTION 1. DEFINITION OF TERMS 2 SECTION 2. ALLOCATION OF TAX LIABILITIES 13 Section 2.01 General Rule 13 Section 2.02 Tax Year Ends 13 Section 2.03 Transfer Taxes 13 SECTION 3. PREPARATION A |
|
| February 4, 2021 |
EX-99.2 6 d11627dex992.htm EX-99.2 Exhibit 99.2 NEWS RELEASE DuPont Announces Final Results of Exchange Offer in Connection with IFF Transaction WILMINGTON, Del., Feb. 3, 2021 – DuPont (NYSE: DD) announced today the final results of its exchange offer, and the final proration factor of 52.5307455 percent, in connection with the previously announced separation of its nutrition and biosciences busin |
|
| February 3, 2021 |
AMENDMENT NO. 2 TO THE SEPARATION AND DISTRIBUTION AGREEMENT EX-99.(d)(xi) Exhibit (d)(xi) EXECUTION COPY AMENDMENT NO. 2 TO THE SEPARATION AND DISTRIBUTION AGREEMENT This Amendment No. 2 (this “Second Amendment”) to the Separation and Distribution Agreement, dated as of December 15, 2019 (the “Original SDA”), as amended by that certain Amendment No. 1 to the Separation and Distribution Agreement, dated as of January 22, 2021 (the “Agreement”), is made as o |
|
| February 3, 2021 |
INTELLECTUAL PROPERTY CROSS-LICENSE AGREEMENT EX-99.(d)(x) Exhibit d(x) Execution Copy INTELLECTUAL PROPERTY CROSS-LICENSE AGREEMENT This INTELLECTUAL PROPERTY CROSS-LICENSE AGREEMENT (this “Agreement”), dated as of February 1, 2021 (the “Effective Date”), is entered into by and between Nutrition & Biosciences, Inc., a Delaware corporation (“Spinco”), the Spinco Licensors and the Spinco Licensees, on the one hand, and DuPont de Nemours, Inc., |
|
| February 3, 2021 |
EX-99.(d)(ix) Exhibit d(ix) EXECUTION COPY TAX MATTERS AGREEMENT BY AND AMONG DUPONT DE NEMOURS, INC., NUTRITION & BIOSCIENCES, INC. AND INTERNATIONAL FLAVOR & FRAGRANCES INC. FEBRUARY 1, 2021 TABLE OF CONTENTS Page SECTION 1. DEFINITION OF TERMS 2 SECTION 2. ALLOCATION OF TAX LIABILITIES 13 Section 2.01 General Rule 13 Section 2.02 Tax Year Ends 13 Section 2.03 Transfer Taxes 13 SECTION 3. PREPAR |
|
| February 3, 2021 |
425 1 d71334d425.htm 425 FILED BY DUPONT DE NEMOURS, INC. PURSUANT TO RULE 425 UNDER THE SECURITIES ACT OF 1933 SUBJECT COMPANY: DUPONT DE NEMOURS, INC. COMMISSION FILE NO. 001-38196 NEWS RELEASE DuPont Announces Final Results of Exchange Offer in Connection with IFF Transaction WILMINGTON, Del., Feb. 3, 2021 – DuPont (NYSE: DD) announced today the final results of its exchange offer, and the fina |
|
| February 3, 2021 |
425 1 d924549d425.htm 425 FILED BY DUPONT DE NEMOURS, INC. PURSUANT TO RULE 425 UNDER THE SECURITIES ACT OF 1933 SUBJECT COMPANY: DUPONT DE NEMOURS, INC. COMMISSION FILE NO. 001-38196 Exchange Offer Last Updated: February 3, 2021 Final Results Based on the final count by the exchange agent, a total of 368,655,051 shares of DuPont common stock were validly tendered (and not withdrawn) in the exchan |
|
| February 3, 2021 |
- AMENDMENT NO. 6 TO SCHEDULE TO-I SC TO-I/A 1 d125432dsctoia.htm AMENDMENT NO. 6 TO SCHEDULE TO-I SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO (Rule 14d-100) TENDER OFFER STATEMENT UNDER SECTION 14(D)(1) OR 13(E)(1) OF THE SECURITIES EXCHANGE ACT OF 1934 AMENDMENT NO. 6 DuPont de Nemours, Inc. (Name of Subject Company (Issuer)) DuPont de Nemours, Inc. (Name of Filing Person (Offeror)) Common Stock, $0.01 p |
|
| February 1, 2021 |
EX-99.1 Exhibit 99.1 NEWS RELEASE DuPont Positioned as Premier Multi-industrial Company, Equipped for Growth and Value Creation, following Completion of IFF and Nutrition & Biosciences Merger Updates Reporting Segments Optimized for Success; Concludes Review of Non-Core Segment WILMINGTON, Del., Feb. 1, 2021 –DuPont (NYSE:DD) announced it is completing today the merger of IFF and Nutrition & Biosc |
|
| February 1, 2021 |
EX-99.2 Updated DuPont Business Reporting Segments Supplemental slides in conjunction with DuPont press release issued on February 1, 2021: “DuPont Positioned as a Premier Multi-industrial Company Equipped for Growth and Value Creation, following Completion of IFF and Nutrition & Biosciences Merger” February 1, 2021 Exhibit 99.2 Water & Protection Safety Solutions Shelter Solutions Water Solutions |
|
| February 1, 2021 |
425 1 d110535d425.htm 425 FILED BY DUPONT DE NEMOURS, INC. PURSUANT TO RULE 425 UNDER THE SECURITIES ACT OF 1933 SUBJECT COMPANY: DUPONT DE NEMOURS, INC. COMMISSION FILE NO. 001-38196 NEWS RELEASE DuPont Positioned as Premier Multi-industrial Company, Equipped for Growth and Value Creation, following Completion of IFF and Nutrition & Biosciences Merger Updates Reporting Segments Optimized for Succ |
|
| February 1, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 1, 2021 DuPont de Nemours, Inc. (Exact name of registrant as specified in its charter) Delaware 001-38196 81-1224539 (State or other jurisdiction of incorporation) (Commissio |
|
| February 1, 2021 |
EX-99.(a)(5)(xxviii) Exhibit (a)(5)(xxviii) NEWS RELEASE DuPont Announces Preliminary Results of Exchange Offer in Connection with IFF Transaction WILMINGTON, Del., Feb. 1, 2021 – DuPont (NYSE: DD) announced today the preliminary results of its exchange offer in connection with the previously announced separation of its nutrition and biosciences business (the “N&B Business”) and merger of Nutritio |
|
| February 1, 2021 |
- AMENDMENT NO. 5 TO SCHEDULE TO-I SC TO-I/A 1 d108927dsctoia.htm AMENDMENT NO. 5 TO SCHEDULE TO-I SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO (Rule 14d-100) TENDER OFFER STATEMENT UNDER SECTION 14(D)(1) OR 13(E)(1) OF THE SECURITIES EXCHANGE ACT OF 1934 AMENDMENT NO. 5 DuPont de Nemours, Inc. (Name of Subject Company (Issuer)) DuPont de Nemours, Inc. (Name of Filing Person (Offeror)) Common Stock, $0.01 p |
|
| February 1, 2021 |
FILED BY DUPONT DE NEMOURS, INC. PURSUANT TO RULE 425 UNDER THE SECURITIES ACT OF 1933 SUBJECT COMPANY: DUPONT DE NEMOURS, INC. COMMISSION FILE NO. 001-38196 Exchange Offer Last Updated: February 1, 2021 Preliminary Results Pursuant to the exchange offer, which expired at one minute after 11:59 p.m., New York City time, on January 29, 2021, and based on a preliminary count by the exchange offer ag |
|
| February 1, 2021 |
425 1 d120792d425.htm 425 FILED BY DUPONT DE NEMOURS, INC. PURSUANT TO RULE 425 UNDER THE SECURITIES ACT OF 1933 SUBJECT COMPANY: DUPONT DE NEMOURS, INC. COMMISSION FILE NO. 001-38196 Exchange Offer Last Updated: January 29, 2021 Final Exchange Ratio The final exchange ratio is 0.7180 shares of N&B Common Stock (as defined below) for each share of DuPont Common Stock (as defined below) that is val |
|
| February 1, 2021 |
425 1 d105341d425.htm 425 FILED BY DUPONT DE NEMOURS, INC. PURSUANT TO RULE 425 UNDER THE SECURITIES ACT OF 1933 SUBJECT COMPANY: DUPONT DE NEMOURS, INC. COMMISSION FILE NO. 001-38196 NEWS RELEASE DuPont Announces Preliminary Results of Exchange Offer in Connection with IFF Transaction WILMINGTON, Del., Feb. 1, 2021 – DuPont (NYSE: DD) announced today the preliminary results of its exchange offer |
|
| January 29, 2021 |
425 1 d82885d425.htm 425 FILED BY DUPONT DE NEMOURS, INC. PURSUANT TO RULE 425 UNDER THE SECURITIES ACT OF 1933 SUBJECT COMPANY: DUPONT DE NEMOURS, INC. COMMISSION FILE NO. 001-38196 Exchange Offer Last Updated: January 28, 2021 Final Exchange Ratio The final exchange ratio is 0.7180 shares of N&B Common Stock (as defined below) for each share of DuPont Common Stock (as defined below) that is vali |
|
| January 28, 2021 |
- AMENDMENT NO. 4 TO SCHEDULE TO-I Amendment No. 4 to Schedule TO-I SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO (Rule 14d-100) TENDER OFFER STATEMENT UNDER SECTION 14(D)(1) OR 13(E)(1) OF THE SECURITIES EXCHANGE ACT OF 1934 AMENDMENT NO. 4 DuPont de Nemours, Inc. (Name of Subject Company (Issuer)) DuPont de Nemours, Inc. (Name of Filing Person (Offeror)) Common Stock, $0.01 par value (Title of Class of Sec |
|
| January 28, 2021 |
425 1 d71132d425.htm 425 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 27, 2021 DuPont de Nemours, Inc. (Exact name of registrant as specified in its charter) Delaware 001-38196 81-1224539 (State or other jurisdiction of |
|
| January 28, 2021 |
425 1 d121079d425.htm 425 FILED BY DUPONT DE NEMOURS, INC. PURSUANT TO RULE 425 UNDER THE SECURITIES ACT OF 1933 SUBJECT COMPANY: DUPONT DE NEMOURS, INC. COMMISSION FILE NO. 001-38196 Exchange Offer Last Updated: January 27, 2021 Final Exchange Ratio The final exchange ratio is 0.7180 shares of N&B Common Stock (as defined below) for each share of DuPont Common Stock (as defined below) that is val |
|
| January 28, 2021 |
Financial Statements and Exhibits, Other Events - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 27, 2021 DuPont de Nemours, Inc. (Exact name of registrant as specified in its charter) Delaware 001-38196 81-1224539 (State or other jurisdiction of incorporation) (Commissio |
|
| January 28, 2021 |
EX-99.1 Exhibit 99.1 NEWS RELEASE DuPont Sets Final Exchange Ratio of 0.7180 in Split-Off Exchange Offer in Connection with IFF Transaction WILMINGTON, Del., Jan. 27, 2021 – DuPont (NYSE: DD) announced today that the final exchange ratio for its exchange offer will be 0.7180 shares of common stock of Nutrition & Biosciences, Inc. (“N&B”) for each share of DuPont common stock that is validly tender |
|
| January 27, 2021 |
425 1 d104741d425.htm 425 FILED BY DUPONT DE NEMOURS, INC. PURSUANT TO RULE 425 UNDER THE SECURITIES ACT OF 1933 SUBJECT COMPANY: DUPONT DE NEMOURS, INC. COMMISSION FILE NO. 001-38196 Exchange Offer Last Updated: January 26, 2021 DuPont de Nemours, Inc. Investor Information On December 31, 2020, DuPont de Nemours, Inc., a Delaware corporation (“DuPont”), commenced an exchange offer (the “exchange |
|
| January 26, 2021 |
EX-99.1 Exhibit 99.1 NEWS RELEASE DuPont Exchange Offer to Expire January 29, 2021 Announces Preliminary Fourth Quarter and Full Year 2020 Total Company and N&B Segment Results WILMINGTON, Del. Jan. 26, 2021 – On December 31, 2020, DuPont (NYSE:DD) commenced its exchange offer (the “Exchange Offer”)1 whereby DuPont stockholders can elect to tender shares of DuPont common stock in exchange for shar |
|
| January 26, 2021 |
- AMENDMENT NO. 3 TO SCHEDULE TO-I Amendment No. 3 to Schedule TO-I SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO (Rule 14d-100) TENDER OFFER STATEMENT UNDER SECTION 14(D)(1) OR 13(E)(1) OF THE SECURITIES EXCHANGE ACT OF 1934 AMENDMENT NO. 3 DuPont de Nemours, Inc. (Name of Subject Company (Issuer)) DuPont de Nemours, Inc. (Name of Filing Person (Offeror)) Common Stock, $0.01 par value (Title of Class of Sec |
|
| January 26, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 26, 2021 DuPont de Nemours, Inc. (Exact name of registrant as specified in its charter) Delaware 001-38196 81-1224539 (State or other jurisdiction of incorporation) (Commissio |
|
| January 26, 2021 |
FILED BY DUPONT DE NEMOURS, INC. PURSUANT TO RULE 425 UNDER THE SECURITIES ACT OF 1933 SUBJECT COMPANY: DUPONT DE NEMOURS, INC. COMMISSION FILE NO. 001-38196 Exchange Offer Last Updated: January 25, 2021 DuPont de Nemours, Inc. Investor Information On December 31, 2020, DuPont de Nemours, Inc., a Delaware corporation (“DuPont”), commenced an exchange offer (the “exchange offer”) for all of the out |
|
| January 25, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 22, 2021 DuPont de Nemours, Inc. (Exact name of registrant as specified in its charter) Delaware 001-38196 81-1224539 (State or other jurisdiction of incorporation) (Commissio |
|
| January 25, 2021 |
EX-10.1 Exhibit 10.1 Execution Copy Amendment to the Employee Matters Agreement This Amendment to the Employee Matters Agreement (this “Amendment”) by and among Nutrition & Biosciences, Inc. (“Spinco”), DuPont de Nemours, Inc. (“Remainco”) and International Flavors & Fragrances Inc. (“RMT Partner” and, together with Spinco and Remainco, the “Parties”) dated as of January 22, 2021. WHEREAS, the Par |
|
| January 25, 2021 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 22, 2021 DuPont de Nemours, Inc. (Exact name of registrant as specified in its charter) Delaware 001-38196 81-1224539 (State or other jurisdiction of incorporation) (Commissio |
|
| January 25, 2021 |
- AMENDMENT NO. 2 TO SCHEDULE TO-I SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO (Rule 14d-100) TENDER OFFER STATEMENT UNDER SECTION 14(D)(1) OR 13(E)(1) OF THE SECURITIES EXCHANGE ACT OF 1934 AMENDMENT NO. 2 DuPont de Nemours, Inc. (Name of Subject Company (Issuer)) DuPont de Nemours, Inc. (Name of Filing Person (Offeror)) Common Stock, $0.01 par value (Title of Class of Securities) 26614N102 (CUSIP Number |
|
| January 25, 2021 |
FILED BY DUPONT DE NEMOURS, INC. PURSUANT TO RULE 425 UNDER THE SECURITIES ACT OF 1933 SUBJECT COMPANY: DUPONT DE NEMOURS, INC. COMMISSION FILE NO. 001-38196 Exchange Offer Last Updated: January 22, 2021 DuPont de Nemours, Inc. Investor Information On December 31, 2020, DuPont de Nemours, Inc., a Delaware corporation (“DuPont”), commenced an exchange offer (the “exchange offer”) for all of the out |
|
| January 25, 2021 |
EX-2.1 2 d59910dex21.htm EX-2.1 Exhibit 2.1 EXECUTION VERSION AMENDMENT NO. 1 TO THE SEPARATION AND DISTRIBUTION AGREEMENT This Amendment No. 1 (this “Amendment”) to the Separation and Distribution Agreement, dated as of December 15, 2019 (the “Agreement”), is made as of January 22, 2021 by and among DuPont de Nemours, Inc., a Delaware corporation (“Remainco”), Nutrition & Biosciences, Inc., a Del |
|
| January 22, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 21, 2021 DuPont de Nemours, Inc. (Exact name of registrant as specified in its charter) Delaware 001-38196 81-1224539 (State or other jurisdiction of incorporation) (Commissio |
|
| January 22, 2021 |
Exhibit 10.1 EXECUTION VERSION MEMORANDUM OF UNDERSTANDING This binding memorandum of understanding (together with the exhibits hereto, this “MOU”) is made and entered into this 22nd day of January, 2021, by and among The Chemours Company (“Chemours”), Corteva, Inc. (“Corteva”), E. I. du Pont de Nemours and Company (“EID”) and DuPont de Nemours, Inc. (f/k/a DowDuPont Inc.) (“DuPont”). “Party” or “ |
|
| January 22, 2021 |
425 1 d48461d425.htm 425 FILED BY DUPONT DE NEMOURS, INC. PURSUANT TO RULE 425 UNDER THE SECURITIES ACT OF 1933 SUBJECT COMPANY: DUPONT DE NEMOURS, INC. COMMISSION FILE NO. 001-38196 Exchange Offer Last Updated: January 21, 2021 DuPont de Nemours, Inc. Investor Information On December 31, 2020, DuPont de Nemours, Inc., a Delaware corporation (“DuPont”), commenced an exchange offer (the “exchange o |
|
| January 22, 2021 |
EX-99.1 Exhibit 99.1 NEWS RELEASE DuPont, Corteva, and Chemours announce resolution of legacy PFAS claims Companies also settle remaining Ohio multi-district PFOA litigation WILMINGTON, Del., Jan. 22, 2021 – DuPont de Nemours, Inc. (NYSE: DD), Corteva, Inc. (NYSE: CTVA) and The Chemours Company (NYSE: CC) today announced they have entered into a binding memorandum of understanding containing a set |
|
| January 21, 2021 |
425 FILED BY DUPONT DE NEMOURS, INC. PURSUANT TO RULE 425 UNDER THE SECURITIES ACT OF 1933 SUBJECT COMPANY: DUPONT DE NEMOURS, INC. COMMISSION FILE NO. 001-38196 Exchange Offer Last Updated: January 20, 2021 DuPont de Nemours, Inc. Investor Information On December 31, 2020, DuPont de Nemours, Inc., a Delaware corporation (“DuPont”), commenced an exchange offer (the “exchange offer”) for all of the |
|
| January 20, 2021 |
425 1 d115561d425.htm 425 FILED BY DUPONT DE NEMOURS, INC. PURSUANT TO RULE 425 UNDER THE SECURITIES ACT OF 1933 SUBJECT COMPANY: DUPONT DE NEMOURS, INC. COMMISSION FILE NO. 001-38196 Exchange Offer Last Updated: January 19, 2021 DuPont de Nemours, Inc. Investor Information On December 31, 2020, DuPont de Nemours, Inc., a Delaware corporation (“DuPont”), commenced an exchange offer (the “exchange |
|
| January 19, 2021 |
FILED BY DUPONT DE NEMOURS, INC. PURSUANT TO RULE 425 UNDER THE SECURITIES ACT OF 1933 SUBJECT COMPANY: DUPONT DE NEMOURS, INC. COMMISSION FILE NO. 001-38196 Exchange Offer Last Updated: January 15, 2021 DuPont de Nemours, Inc. Investor Information On December 31, 2020, DuPont de Nemours, Inc., a Delaware corporation (“DuPont”), commenced an exchange offer (the “exchange offer”) for all of the out |
|
| January 15, 2021 |
425 1 d108075d425.htm 425 FILED BY DUPONT DE NEMOURS, INC. PURSUANT TO RULE 425 UNDER THE SECURITIES ACT OF 1933 SUBJECT COMPANY: DUPONT DE NEMOURS, INC. COMMISSION FILE NO. 001-38196 Exchange Offer Last Updated: January 14, 2021 DuPont de Nemours, Inc. Investor Information On December 31, 2020, DuPont de Nemours, Inc., a Delaware corporation (“DuPont”), commenced an exchange offer (the “exchange |
|
| January 15, 2021 |
425 1 d282467d425.htm 425 FILED BY DUPONT DE NEMOURS, INC. PURSUANT TO RULE 425 UNDER THE SECURITIES ACT OF 1933 SUBJECT COMPANY: DUPONT DE NEMOURS, INC. COMMISSION FILE NO. 001-38196 On December 15, 2019, DuPont de Nemours, Inc. (DuPont) announced a definitive agreement to merge its Nutrition & Biosciences business (N&B) with International Flavors & Fragrances Inc. (IFF). Pending satisfaction of |
|
| January 14, 2021 |
FILED BY DUPONT DE NEMOURS, INC. PURSUANT TO RULE 425 UNDER THE SECURITIES ACT OF 1933 SUBJECT COMPANY: DUPONT DE NEMOURS, INC. COMMISSION FILE NO. 001-38196 Exchange Offer Last Updated: January 13, 2021 DuPont de Nemours, Inc. Investor Information On December 31, 2020, DuPont de Nemours, Inc., a Delaware corporation (“DuPont”), commenced an exchange offer (the “exchange offer”) for all of the out |
|
| January 13, 2021 |
FILED BY DUPONT DE NEMOURS, INC. PURSUANT TO RULE 425 UNDER THE SECURITIES ACT OF 1933 SUBJECT COMPANY: DUPONT DE NEMOURS, INC. COMMISSION FILE NO. 001-38196 Exchange Offer Last Updated: January 12, 2021 DuPont de Nemours, Inc. Investor Information On December 31, 2020, DuPont de Nemours, Inc., a Delaware corporation (“DuPont”), commenced an exchange offer (the “exchange offer”) for all of the out |
|
| January 12, 2021 |
425 1 d105241d425.htm 425 FILED BY DUPONT DE NEMOURS, INC. PURSUANT TO RULE 425 UNDER THE SECURITIES ACT OF 1933 SUBJECT COMPANY: DUPONT DE NEMOURS, INC. COMMISSION FILE NO. 001-38196 Exchange Offer Last Updated: January 11, 2021 DuPont de Nemours, Inc. Investor Information On December 31, 2020, DuPont de Nemours, Inc., a Delaware corporation (“DuPont”), commenced an exchange offer (the “exchange |
|
| January 11, 2021 |
425 1 d94849d425.htm 425 FILED BY DUPONT DE NEMOURS, INC. PURSUANT TO RULE 425 UNDER THE SECURITIES ACT OF 1933 SUBJECT COMPANY: DUPONT DE NEMOURS, INC. COMMISSION FILE NO. 001-38196 Exchange Offer Last Updated: January 8, 2021 DuPont de Nemours, Inc. Investor Information On December 31, 2020, DuPont de Nemours, Inc., a Delaware corporation (“DuPont”), commenced an exchange offer (the “exchange of |
|
| January 11, 2021 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO (Rule 14d-100) TENDER OFFER STATEMENT UNDER SECTION 14(D)(1) OR 13(E)(1) OF THE SECURITIES EXCHANGE ACT OF 1934 AMENDMENT NO. 1 DuPont de Nemours, Inc. (Name of Subject Company (Issuer)) DuPont de Nemours, Inc. (Name of Filing Person (Offeror)) Common Stock, $0.01 par value (Title of Class of Securities) 26614N102 (CUSIP Number |
|
| January 8, 2021 |
425 1 d56728d425.htm 425 FILED BY DUPONT DE NEMOURS, INC. PURSUANT TO RULE 425 UNDER THE SECURITIES ACT OF 1933 SUBJECT COMPANY: DUPONT DE NEMOURS, INC. COMMISSION FILE NO. 001-38196 Exchange Offer Last Updated: January 7, 2021 DuPont de Nemours, Inc. Investor Information On December 31, 2020, DuPont de Nemours, Inc., a Delaware corporation (“DuPont”), commenced an exchange offer (the “exchange of |
|
| January 7, 2021 |
425 1 d41677d425.htm 425 FILED BY DUPONT DE NEMOURS, INC. PURSUANT TO RULE 425 UNDER THE SECURITIES ACT OF 1933 SUBJECT COMPANY: DUPONT DE NEMOURS, INC. COMMISSION FILE NO. 001-38196 Exchange Offer Last Updated: January 6, 2021 DuPont de Nemours, Inc. Investor Information On December 31, 2020, DuPont de Nemours, Inc., a Delaware corporation (“DuPont”), commenced an exchange offer (the “exchange of |
|
| January 6, 2021 |
425 1 d107373d425.htm 425 FILED BY DUPONT DE NEMOURS, INC. PURSUANT TO RULE 425 UNDER THE SECURITIES ACT OF 1933 SUBJECT COMPANY: DUPONT DE NEMOURS, INC. COMMISSION FILE NO. 001-38196 Exchange Offer Last Updated: January 5, 2021 DuPont de Nemours, Inc. Investor Information On December 31, 2020, DuPont de Nemours, Inc., a Delaware corporation (“DuPont”), commenced an exchange offer (the “exchange o |
|
| January 5, 2021 |
425 FILED BY DUPONT DE NEMOURS, INC. PURSUANT TO RULE 425 UNDER THE SECURITIES ACT OF 1933 SUBJECT COMPANY: DUPONT DE NEMOURS, INC. COMMISSION FILE NO. 001-38196 On December 15, 2019, DuPont de Nemours, Inc. (“DuPont”) and International Flavors & Fragrances, Inc. (“IFF”) announced that they had reached a definitive agreement to combine the DuPont Nutrition & Biosciences business with IFF, (the “N& |
|
| January 5, 2021 |
FILED BY DUPONT DE NEMOURS, INC. PURSUANT TO RULE 425 UNDER THE SECURITIES ACT OF 1933 SUBJECT COMPANY: DUPONT DE NEMOURS, INC. COMMISSION FILE NO. 001-38196 Exchange Offer Last Updated: January 4, 2021 DuPont de Nemours, Inc. Investor Information On December 31, 2020, DuPont de Nemours, Inc., a Delaware corporation (“DuPont”), commenced an exchange offer (the “exchange offer”) for all of the outs |
|
| January 4, 2021 |
FILED BY DUPONT DE NEMOURS, INC. PURSUANT TO RULE 425 UNDER THE SECURITIES ACT OF 1933 SUBJECT COMPANY: DUPONT DE NEMOURS, INC. COMMISSION FILE NO. 001-38196 Exchange Offer Last Updated: December 31, 2020 DuPont de Nemours, Inc. Investor Information On December 31, 2020, DuPont de Nemours, Inc., a Delaware corporation (“DuPont”), commenced an exchange offer (the “exchange offer”) for all of the ou |
|
| December 31, 2020 |
425 FILED BY DUPONT DE NEMOURS, INC. PURSUANT TO RULE 425 UNDER THE SECURITIES ACT OF 1933 SUBJECT COMPANY: DUPONT DE NEMOURS, INC. COMMISSION FILE NO. 001-38196 NEWS RELEASE DuPont Launches Split-Off Exchange Offer for its Nutrition and Biosciences Business and Announces Record Date for Expected Clean-Up Spin-Off in Connection with IFF Transaction WILMINGTON, Del., December 31, 2020 – DuPont (NYS |
|
| December 31, 2020 |
EX-99.(a)(1)(viii) Exhibit (a)(1)(viii) IMMEDIATE ATTENTION REQUIRED December 31, 2020 Re: Exchange Offer for Shares of Nutrition & Biosciences, Inc – RESPONSE DUE NO LATER THAN JANUARY 28, 2021, AT 3 PM, EASTERN STANDARD TIME Dear Plan Participant: You are receiving this letter because our records reflect that you are a participant in the DuPont Retirement Savings Plan (“DuPont RSP” or the “Plan” |
|
| December 31, 2020 |
EX-99.(a)(1)(ix) Exhibit (a)(1)(ix) DuPont de Nemours, Inc.’s Separation of the Nutrition & Biosciences business and its Combination with International Flavors & Fragrances Inc. IMMEDIATE ATTENTION REQUIRED You are being contacted because you are a participant in a Du Pont UK Share Incentive Plan (“SIP”) or you hold shares in DuPont de Nemours, Inc. (“DuPont”) in the “DuPont Share Shop” (“Share Sh |
|
| December 31, 2020 |
EX-99.(a)(5)(ii) Exhibit (a)(5)(ii) NEWS RELEASE DuPont Launches Split-Off Exchange Offer for its Nutrition and Biosciences Business and Announces Record Date for Expected Clean-Up Spin-Off in Connection with IFF Transaction WILMINGTON, Del., December 31, 2020 – DuPont (NYSE: DD) today announced the commencement of its exchange offer (split-off) whereby DuPont stockholders can elect to tender shar |
|
| December 31, 2020 |
SC TO-I SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO (Rule 14d-100) TENDER OFFER STATEMENT UNDER SECTION 14(D)(1) OR 13(E)(1) OF THE SECURITIES EXCHANGE ACT OF 1934 DuPont de Nemours, Inc. (Name of Subject Company (Issuer)) DuPont de Nemours, Inc. (Name of Filing Person (Offeror)) Common Stock, $0.01 par value (Title of Class of Securities) 26614N102 (CUSIP Number of Class |
|
| December 29, 2020 |
EX-10.1 Exhibit 10.1 Execution Version AMENDED AND RESTATED EMPLOYMENT AGREEMENT This AMENDED AND RESTATED EMPLOYMENT AGREEMENT (this “Agreement”) is hereby entered into as of December 28, 2020 (the “Effective Date”) by and between DuPont de Nemours, Inc. (the “Company”) and Edward D. Breen (the “Executive” and, together with the Company, the “Parties” and each a “Party”). RECITALS WHEREAS, the Pa |
|
| December 29, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 28, 2020 DuPont de Nemours, Inc. (Exact name of registrant as specified in its charter) Delaware 001-38196 81-1224539 (State or other jurisdiction of incorporation) (Commissi |
|
| December 18, 2020 |
FILED BY DUPONT DE NEMOURS, INC. PURSUANT TO RULE 425 UNDER THE SECURITIES ACT OF 1933 SUBJECT COMPANY: DUPONT DE NEMOURS, INC. COMMISSION FILE NO. 001-38196 NEWS RELEASE DuPont Board of Directors Approves the Separation of DuPont’s Nutrition & Biosciences Business through an Exchange Offer WILMINGTON, Del., December 18, 2020 – DuPont (NYSE: DD) today announced that its Board of Directors has appr |
|
| December 7, 2020 |
EX-99.1 EXHIBIT 99.1 FOR IMMEDIATE RELEASE IFF Contact Information Michael DeVeau [email protected] +1 212-708-7164 DuPont Investors: Leland Weaver [email protected] +1 302-999-2477 DuPont Media: Dan Turner [email protected] +1 302-299-7628 IFF Receives All Required Antitrust Clearances for Intended Combination with DuPont’s Nutrition & Biosciences Business Transaction Remains |
|
| December 7, 2020 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 7, 2020 DuPont de Nemours, Inc. (Exact name of registrant as specified in its charter) Delaware 001-38196 81-1224539 (State or other jurisdiction of incorporation) (Commissio |
|
| December 7, 2020 |
425 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 7, 2020 DuPont de Nemours, Inc. (Exact name of registrant as specified in its charter) Delaware 001-38196 81-1224539 (State or other jurisdiction of incorporation) (Commi |
|
| December 4, 2020 |
425 1 d17607d425.htm 425 N&B Update on IFF Transaction* December 2020 Nutrition & Biosciences *The combined company will be formed upon the merger closing, subject to regulatory approval and customary closing conditions. FILED BY DUPONT DE NEMOURS, INC. PURSUANT TO RULE 425 UNDER THE SECURITIES ACT OF 1933 SUBJECT COMPANY: DUPONT DE NEMOURS, INC. COMMISSION FILE NO. 001-38196 DuPont N&B and IFF Co |
|
| October 30, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-38196 DUPONT DE NEMOURS, INC. (Exact name of registrant |
|
| October 30, 2020 |
425 FILED BY DUPONT DE NEMOURS, INC. PURSUANT TO RULE 425 UNDER THE SECURITIES ACT OF 1933 SUBJECT COMPANY: DUPONT DE NEMOURS, INC. COMMISSION FILE NO. 001-38196 The following are excerpts from DuPont de Nemours, Inc.’s earnings press release and earnings slides issued on October 29, 2020 and from the transcript from its earnings call held on October 29, 2020. Excerpt from Earnings Press Release B |
|
| October 29, 2020 |
DuPont Reports Third Quarter 2020 Results EX-99.1 2 exhibit991enrschedules.htm EX-99.1 Exhibit 99.1 DuPont Reports Third Quarter 2020 Results •3Q20 GAAP EPS from continuing operations of $(0.11); adjusted EPS of $0.88 •3Q20 Net Sales of $5.1 billion, down 6 percent; organic sales down 6 percent •3Q20 GAAP Loss from continuing operations of $(72) million and Operating EBITDA of $1.3 billion •$150 million in non-manufacturing costs savings |
|
| October 29, 2020 |
Financial Statements and Exhibits, Results of Operations and Financial Condition - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 29, 2020 DuPont de Nemours, Inc. (Exact name of registrant as specified in its charter) Delaware 001-38196 81-1224539 (State or other jurisdiction of incorporation) (Commissio |
|
| September 10, 2020 |
FILED BY DUPONT DE NEMOURS, INC. PURSUANT TO RULE 425 UNDER THE SECURITIES ACT OF 1933 SUBJECT COMPANY: DUPONT DE NEMOURS, INC. COMMISSION FILE NO. 001-38196 On September 9, 2020, International Flavors & Fragrances Inc. (IFF) and DuPont de Nemours, Inc. (DuPont) issued the following news release: IFF & DuPont Announce Pricing of $6.25 Billion Senior Notes Offering by Nutrition & Biosciences, Inc. |
